The UK government has shown support for adaptive licensing as a key tool to promote innovation in the pharmaceutical industry. In fact, life science champions in the UK regard adaptive licensing as a "particularly important regulatory reform for small and medium sized enterprises, which could potentially transform the life cycle of small companies and provide earlier access".
展开▼
